Absence of long‐term analgesic effect from a short‐term S‐ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo‐controlled trial
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
To assess the analgesic efficacy of the N‐methyl‐D‐aspartate receptor antagonist S(+)‐ketamine on fibromyalgia pain, the authors performed a randomized double blind, active placebo‐controlled trial. Twenty‐four fibromyalgia patients were randomized to receive a 30‐min intravenous infusion with S(+)‐ketamine (total dose 0.5 mg/kg,n=12) or the active placebo, midazolam (5 mg,n=12). Visual Analogue Pain Scores (VAS) and ketamine plasma samples were obtained for 2.5‐h following termination of treatment; pain scores derived from the fibromyalgia impact questionnaire (FIQ) were collected weekly during an 8‐week follow‐up. Fifteen min after termination of infusion the number of patients showing a reduction in pain scores >50% was 8 vs. 3 (P<0.05), at t=180 min 6 vs. 2 (ns), at the end of week‐1 2 vs. 0 (ns) and at end of week‐8 2 vs. 2 in the ketamine and midazolam groups, respectively. Ketamine effect on VAS closely followed ketamine plasma concentrations. For VAS and FIQ scores no significant differences in treatment effects were observed in the 2.5‐h following infusion or during the 8‐week follow‐up. Side effects as measured by the Bowdle questionnaire (which scores for 13 separate psychedelic symptoms) were mild to moderate in both study groups and declined rapidly, indicating adequate blinding of treatments. Efficacy of ketamine was limited and restricted in duration to its pharmacokinetics. The authors argue that a short‐term infusion of ketamine is insufficient to induce long‐term analgesic effects in fibromyalgia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“All of these effects are thought to arise from a cascade of molecular changes at spinal and supraspinal sites that was initiated by blockade of the NMDAR by ketamine (Chizh, 2007; Christoph et al., 2006; Li et al., 2010; Rabben et al., 1999; Sigtermans et al., 2009a,b; 2010).”
BackgroundManagement of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850 · cited 2×
“Prevalence is 2–3% with predominance for women (sex ratio 1:7) (Goldenberg et al., 2004).”
BackgroundPfenninger, E. G., Durieux, M. E., & Himmelseher, S. (2002) · Anesthesiology · doi:10.1097/00000542-200202000-00022 · Cited by 189
Cited by
Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
Ketamine for chronic pain: risks and benefits
Niesters, M., Martini, C., & Dahan, A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12094 · Cited by 508
Self-citationKetamine: 50 Years of Modulating the Mind
Li, L., & Vlisides, P. E. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00612 · Cited by 385
Cohen, S. P., Bhatia, A., Buvanendran, A., Schwenk, E. S., Wasan, A. D., Hurley, R. W., Viscusi, E. R., Narouze, S., Davis, F. N., Ritchie, E. C., et al. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000808 · Cited by 350
Orhurhu, V., Orhurhu, M. S., Bhatia, A., & Cohen, S. P. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004185 · Cited by 179
Dadabayev, A. R., Joshi, S. A., Reda, M. H., Lake, T., Hausman, M. S., Domino, E., & Liberzon, I. (2020) · Chronic Stress · doi:10.1177/2470547020981670 · Cited by 37
Kim, M., Cho, S., & Lee, J.-H. (2016) · Pain Medicine · doi:10.1093/pm/pnv112 · Cited by 30
Metadata
- Authors
- Noppers, I., Niesters, M., Swartjes, M., Bauer, M., Aarts, L., Geleijnse, N., Mooren, R., Dahanl, A., & Sarton, E.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 15
- Issue
- 9
- Pages
- 942-949
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W1976294695
- Cited by
- 95
- References
- 4
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.